Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISCO-RLS: Ropinirole and Gabapentin for RLS in ESRD
NCT03806530Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- May 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropinirole, gabapentin in restless legs syndrome (RLS), sponsored by Population Health Research Institute. Started May 2019; status: completed.
02
Drugs
ropinirolegabapentin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT03806530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806530.